Joint Formulary & PAD

Adefovir dipivoxil - Hepatitis B

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Non Formulary
Formulations :
  • Tablets
Associated Icons :
BNF SPC
NHSE
Restrictions / Comments :
Important
Not recommended in line with NICE CG165

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Adefovir dipivoxil
Indication :
Hepatitis B
Group Name :
Keywords :
antiviral
Brand Names Include :
Hepsera
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Adefovir dipivoxil is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Hepatitis B.

Committee Recommendations (1)

This drug / device falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.
Treatment should remain with the specialist (RED) hospital only drug.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.